ChronoScale Corporation (CHRN)
NASDAQ: CHRN · Real-Time Price · USD
15.16
-0.33 (-2.13%)
At close: May 26, 2026, 4:00 PM EDT
15.81
+0.65 (4.29%)
After-hours: May 26, 2026, 7:36 PM EDT
ChronoScale Revenue
ChronoScale had revenue of $2.14M in the quarter ending March 31, 2026, a decrease of -36.56%. This brings the company's revenue in the last twelve months to $11.57M, down -34.08% year-over-year. In the year 2025, ChronoScale had annual revenue of $12.80M, down -28.60%.
Revenue (ttm)
$11.57M
Revenue Growth
-34.08%
P/S Ratio
25.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.80M | -5.13M | -28.60% |
| Dec 31, 2024 | 17.93M | -354.00K | -1.94% |
| Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
| Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
| Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
| Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
| Dec 31, 2019 | 13.92M | 2.59M | 22.81% |
| Dec 31, 2018 | 11.33M | 3.98M | 54.11% |
| Dec 31, 2017 | 7.35M | -6.87M | -48.29% |
| Dec 31, 2016 | 14.22M | 5.56M | 64.20% |
| Dec 31, 2015 | 8.66M | 3.33M | 62.59% |
| Dec 31, 2014 | 5.33M | 2.03M | 61.33% |
| Dec 31, 2013 | 3.30M | 596.00K | 22.03% |
| Dec 31, 2012 | 2.71M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCHRN News
- 20 days ago - ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth - GlobeNewsWire
- 4 months ago - Ekso Bionics Prices $5.852 million Private Placement - GlobeNewsWire
- 5 months ago - Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale - GlobeNewsWire
- 6 months ago - Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System - GlobeNewsWire
- 7 months ago - Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules - GlobeNewsWire
- 7 months ago - Ekso Bionics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 10 months ago - Ekso Bionics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 11 months ago - Ekso Bionics to Report Second Quarter 2025 Financial Results on July 28 – Conference Call to Follow - GlobeNewsWire